Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)

:2179

2179

Jiangsu Recbio Technology Co., Ltd. Class H

RESEARCH TOOLSreports

Compare Jiangsu Recbio Technology Co., Ltd. Class H (2179) vs. Competitors

1 Followers

Comparison Results

2179

Jiangsu Recbio Technology Co., Ltd. Class H

HK$4.18

HK$2.35B

-3.21

-29.19%

―

TOT BIOPHARM International Co. Ltd.

HK$2.50

HK$3.76B

-16.66

185.88%

―

Lepu Biopharma Co. Ltd. Class H

HK$4.98

HK$10.74B

30.77

58.83%

―

CStone Pharmaceuticals

HK$5.34

HK$14.64B

-15.44

335.93%

2 Buy

0 Hold

0 Sell

Moderate Buy

SinoMab Bioscience Ltd.

HK$1.39

HK$2.24B

-14.44

44.25%

―

xxxxxxxxxxxxx

2179 vs 3681

xxxxxxxxxxxxx

Performance Comparison

HK:2179

Jiangsu Recbio Technology Co., Ltd. Class H

4.90

-2.02

-29.19%

HK:1875

TOT BIOPHARM International Co. Ltd.

4.86

3.23

198.16%

HK:2157

Lepu Biopharma Co. Ltd. Class H

5.78

1.61

38.61%

HK:2616

CStone Pharmaceuticals

10.07

7.40

277.15%

HK:3681

SinoMab Bioscience Ltd.

1.63

0.48

41.74%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >